HOME › DRUGS › BALOXAVIR MARBOXIL
ACTIVE SUBSTANCE / INN

BALOXAVIR MARBOXIL

Brand name(s): Xofluza, XOFLUZA
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
Influenza, Human
NDA210854
ACTIVE SUBSTANCE
Baloxavir Marboxil
REGULATORS
FDA · EMA
SPONSORS / MAH
Roche Registration GmbH, GENENTECH INC
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
XOFLUZANDA210854GENENTECH INCPrescription
XOFLUZANDA210854GENENTECH INCDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
XofluzaRoche Registration GmbHAuthorised07/01/2021Influenza, Human

FULL INTELLIGENCE ON BALOXAVIR MARBOXIL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →